The US Food and Drug Administration has issued draft guidance to help infant formula manufacturers comply with requirements that all claims in labels be "truthful and not misleading".
The update relates to 'structure/function' claims about the effects of a product on the "normal structure or function of the body - such as a statement that a formula "supports digestion".
In the draft guidance the FDA describes its recommendations for the type and quality of scientific evidence that is appropriate to substantiate claims.
Comments on the document are now being sought - for full details see www.fda.gov.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Sep 16